Drugs & TargetsFree FDA approves Herzuma, equivalent of Herceptin, in indications March 20, 2020Vol.46 No.12
Clinical RoundupFree Pembrolizumab shows promise for some advanced, hard-to-treat rare cancers March 20, 2020Vol.46 No.12
Clinical RoundupFree Study suggests link between BMI, nutritional markers, and chemotherapy toxicity in older adults with tumors March 20, 2020Vol.46 No.12
COVID-19 & CancerFreeTrials & Tribulations What community cancer centers need to know about COVID-19 March 20, 2020Vol.46 No.12By Jeff Patton and Lee Schwartzberg
FreeIn Brief NCCN releases recommendations for standardizing quality measurements in oncology March 20, 2020Vol.46 No.12
FreeIn Brief UCLA awarded $2.7 million to study AI role in improving cancer diagnosis March 20, 2020Vol.46 No.12
Conversation with The Cancer LetterCOVID-19 & CancerFree Curigliano: “I don’t want to see more people dying”As COVID-19 deaths rise in Italy, oncologists hope to see the curve flatten March 20, 2020Vol.46 No.12By Alexandria Carolan
